Furthermore, IGF-1 in tibia bone marrow was increased in metastasized bone cancer pain model, while intraperitoneal injection IGF-1R inhibitor (PPP, 20 mg/kg/12 h) in vivo can reverse mechanical allodynia and thermal hyperalgesia in rats with bone cancer pain73. This evidence concerns the gene IGF1 and bone neoplasm.